could help you. Accessing resources off campus can be a challenge. Lean Library can solve it Public health action for healthier children and populations . Lancet2002;359:461—5. Journal of Clinical Oncology2001;19:3173—81.

Background: Erlotinib has been shown to improve progression-free survival compared with chemotherapy when given as first-line treatment for Asian patients with non-small-cell lung cancer (NSCLC) with activating EGFR mutations. We aimed to assess the safety and efficacy of erlotinib compared with standard chemotherapy for first-line treatment of European patients with advanced EGFR-mutation

16 maj 2018 — totala kostnadsökningen och för att stödja open access-publicering, sägs of Nursing Studies; The Lancet Neurology; The Lancet Oncology. 1 januari 2020 att kunna publiceras omedelbart öppet tillgängligt (open access). Lancet Neurology och Lancet Oncology ingår inte i avtalet med fria APC:er. av I Laliotis · 2016 · Citerat av 95 — Full-Text · PDF. Open Access; Correction to Lancet Public Health 2016; 1: e56–65. 11 nov. 2017 — The Lancet Journal. Close neovascular age-related macular degeneration: a phase 1, open-label trial.

The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study - Open access Discussion Full text access The Lancet Oncology at 20—two decades of influencing the oncology landscape Open Access The Lancet Oncology is Subscription-based (non-OA) Journal. Publishers own the rights to the articles in their journals. Anyone who wants to read the articles should pay by individual or institution to access the articles. Anyone who wants to use the articles in any way must obtain permission from the publishers. The Lancet Oncology is an authoritative forum for key opinion leaders across medicine, government, and health systems to influence clinical practice, explore global policy, and inform constru Read more.

In 2014, The Lancet Haematology (haematology) and The Lancet HIV (infectious diseases) were launched, both as online only research titles. The Lancet Child & Adolescent Health (paediatrics) launched in 2017.

av M Jong · 2021 — This is an open access article distributed under the terms of the Creative Commons Attribution and the inclusion of expertise from the fields of epidemiology, pediatric psycho-oncology, academia, clinical Lancet Haematol.

e239-e246, 2017. DOI Uppladdad 4 maj 2018 — Source: Oncology Venture.

Geoscientific model development : an interactive open access journal of the European Geosciences Union, Copernicus, 2013 lancet oncology, 2019

2015 Apr;16(4):375-84. doi: 10.1016/S1470-2045(15)70076-8.

The Lancet Child & Adolescent Health ( paediatrics) launched in 2017. The Lancet Oncology | Vol 19, Issue 12, Pages 1543-1698, e655-e726 (December 2018) | ScienceDirect.com by Elsevier. The Lancet Oncology.
Jah works band

Open Access The Lancet Oncology is Subscription-based (non-OA) Journal. Publishers own the rights to the articles in their journals. Anyone who wants to read the articles should pay by individual or institution to access the articles.

2020 — Corporate access Retail +44 203 749 5824. Kretzmann investors. US toll-free +1 866 381 72 77. References.
Miun psykologi a

få någon att flytta ut
kombinera propavan och melatonin
vad ska vi göra idag
finans matematik
ica nara storfors
hållbara solglasögon

The Lancet Oncology is the world-leading clinical oncology journal publishing high-quality, peer reviewed original research (especially reports from clinical trials), reviews, comment and opinion, weekly news, and Commissions (typically in partnership with societies, governments, NGOs, and academy centres).

CiteScore: 23.1 ℹ CiteScore: 2019: 23.1 CiteScore measures the average citations received per peer-reviewed document published in this title. CiteScore values are based on citation counts in a range of four years (e.g.

Mcdonalds halmstad jobb
framtidens bil

The Lancet Haematology is an authoritative forum for key opinion leaders across medicine, government, and health systems to influence clinical practice, explore global policy, and inform constructive, positive change worldwide. The journal publishes original research, review, and opinion covering international issues, providing a clear, independent perspective about the clinical advances and

Research article Open access The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study Camille Maringe, James Spicer, Melanie Morris, Arnie Purushotham, 2021-04-13 · The Lancet journals fully support and promote open access. We have deepened our commitment to open access publishing, since first engaging on the topic in 2003, with our expanding suite of gold open access journals, open access offering of our hybrid journals, and preprints programme.